Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fluorescein for Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Stage I and II Malignant Melanoma

NCT00847522 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT00847522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00847522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fluorescein for Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Stage I and II Malignant Melanoma
Lead sponsor
University of Utah
Phase
Phase 1/2
Overall status
Completed
Start date
February 28, 2009
Completion date
July 31, 2016
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer